Electron microscopic findings in skin biopsies from patients with danon disease

Ultrastructural Pathology

Volumn 34, Issue 6, 2010, Pages 333-336

  Alroy, Joseph ^a,b   Pfannl, Rolf ^b   Slavov, Dobromir ^c   Taylor, Matthew R G ^c  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Danon disease; Fibroblasts; Lysosomal storage disease; Skin; Ultrastructure

Indexed keywords

LAMP2 PROTEIN, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN;

ADULT; ARTICLE; BIOPSY; CELL CULTURE; CHILD; DANON DISEASE; FEMALE; FIBROBLAST; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE; SKIN; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADULT; BIOPSY; CELLS, CULTURED; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROBLASTS; GLYCOGEN STORAGE DISEASE TYPE IIB; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; PEDIGREE; SKIN;

EID: 78349286926     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2010.499024     Document Type: Article

References (24)

1. Danon MJ, Oh SJ, DiMauro S, Manaligod JE, et al. Lysosomal storage disease with normal acid maltase. Neurology. 1981;3:151-157.
2. Morisawa Y, Fujieda M, Murakmi N, et al. Lysosomal glycogen storage disease with normal acid maltase with early fatal outcome. J Neurol Sci. 1998;160:175-179.
3. Lacoste-Collin L, Garcia V, Uro-Coste E, et al. Danons disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation. Neuromus Disord. 2002;12:882-885.
4. Fanin M, Nascimbeni AC, Fulizio L, et al. Generalized lysosomal-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am J Pathol. 2006;168:1309-1320.
5. Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy andmyopaty (Danon disease). Nature. 2000;406:906-910.
6. Doug N, Joho S, Shan L, et al. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Circulation. 2009;73:376-380.
7. Sugie K, Yamamoto Y, Murayama K, et al. Clinicopathologic features of genetically confirmed Danon disease. Neurology. 2002;58:1773-1778.
8. Burusnukul P, de los Reyes EC, Yinger J, Boue DR. Danon disease: an unusual presentation with autism. Pediatr Neurol. 2008;39:151-157.
9. Prall FR, Drack A, Taylor M, et al. Ophthalmic manifestations of Danon disease. Ophthalmology. 2006;113:1010-1013.
10. Schorderet D, Cottet S, Lobrinus JA, et al. Retinopathy in Danon disease. Arch Ophthalmol. 2007;125:231-236.
11. van der Kooi AJ, van Langen IM, Aronica E, et al. Extension of clinical spectrum of Danon disease. Neurology. 2008;70:1358-1359.
12. Lobrinus JA, Schorderet DF, Payot M, et al. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease). Neuromus Disord. 2005;15:293-298.
13. Sabourdy F, Michelakakis H, Anastasakis A, et al. Danon disease: further clinical and molecular heterogeneity. Muscle Nerve. 2009;39:837-844.
14. Tse H-F, Shek TWK, Tai Y-T, Lau Y-K, Ma L. Case report: lysosomal clycogen storage disease with normal acid maltase: An unusual form of hypertrophic cardiomyopathy with rapidly progressive heart failure. Am J Med Sci. 1996;12:182-186.
15. Tunon T, Guerrero D, Urchaga A, et al. Danon disease: a novel Lamp-2 gene mutation in a family with four affected members. Neuromus Disord. 2008;18:167-174.
16. Usuki F, Takenaga S, Higushi I, et al. Morphologic findings in biopsied skeletal muscle and cultured fibroblasts from a female patients with Danons disease (lysosomal glycogen strorage disease without acid maltase deficiency). J Neurol. 1994:127:54-60.
17. Alroy J, Ucci AA. Skin biopsy: a useful tool in the diagnosis of lysosomal storage diseases. Ultrastruct Pathol. 2006;30:489-503.
18. Alroy J, Pfannl R, Ucci A. Electron microscopic findings in skin biopsies from patients with infantile osteopetrosis and neuronal storage disease. Ultrastruct Pathol. 2007;31:1-6.
19. Taylor MRG, Ku L, Slavov D, et al. Danon disease presented with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007;52:830-835.
20. Banwell B. X-linked vacuolar myopathies. In: Engel AG, Laurea CF-A, eds. Myology: Basic and Clinical. New York: McGraw-Hill; 2004:1163-1168.
21. Ramachandran N, Munteanu I, Wang P, et al. VMA21 deficiency causes by an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification. Cell. 2009;137:235-246.
22. Pironi M, Chimenti C, De Cobelli F, et al. Fabry disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am College Cardiol. 2006:47:1663-1671.
23. Uchino M, Uyama E, Kawano H, et al. A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier. Acta Neuropathol. 1995;90:334-338.
24. Castagnaro M, Alroy J, Ucci AA, Glew RH. Lectin histochemistry and ultrastructure of cat kidneys from six different storage diseases. Virchows Arch B Cell Pathol. 1987;54:16-26.